SEC Form 4 research
| Issuer | Trevi Therapeutics, Inc. |
|---|---|
| Tickers | TRVI |
| Reporting owners | 53 |
| Officers and directors | 9 |
| Last public filing | 2026-09-17 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-17 | 2026-09-15 | Heffernan Michael Thomas | S | 100 | $15.88 | Not reported |
| 2026-09-17 | 2026-09-15 | Heffernan Michael Thomas | S | 20,952 | $15.09 | Not reported |
| 2026-09-17 | 2026-09-15 | Heffernan Michael Thomas | S | 100 | $15.88 | Not reported |
| 2026-09-17 | 2026-09-15 | Heffernan Michael Thomas | S | 18,321 | $15.09 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.